Product Name :
Tiludronate disodium
Description:
Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties.
CAS:
149845-07-8
Molecular Weight:
362.57
Formula:
C7H7ClNa2O6P2S
Chemical Name:
disodium hydrogen {[(4-chlorophenyl)sulfanyl](hydrogen phosphonato)methyl}phosphonate
Smiles :
[Na+].[Na+].[O-]P(O)(=O)C(SC1C=CC(Cl)=CC=1)P([O-])(O)=O
InChiKey:
SKUHWSDHMJMHIW-UHFFFAOYSA-L
InChi :
InChI=1S/C7H9ClO6P2S.2Na/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14;;/h1-4,7H,(H2,9,10,11)(H2,12,13,14);;/q;2*+1/p-2
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties.|Product information|CAS Number: 149845-07-8|Molecular Weight: 362.57|Formula: C7H7ClNa2O6P2S|Chemical Name: disodium hydrogen {[(4-chlorophenyl)sulfanyl](hydrogen phosphonato)methyl}phosphonate|Smiles: [Na+].[Na+].[O-]P(O)(=O)C(SC1C=CC(Cl)=CC=1)P([O-])(O)=O|InChiKey: SKUHWSDHMJMHIW-UHFFFAOYSA-L|InChi: InChI=1S/C7H9ClO6P2S.2Na/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14;;/h1-4,7H,(H2,9,10,11)(H2,12,13,14);;/q;2*+1/p-2|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: H2O : 62.5 mg/mL (172.38 mM; Need ultrasonic).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|The ability of Tiludronate to inhibit proton transport is 5-fold higher in kidney-derived vesicles (IC50=1.1 mM) and 10,000-fold higher in vesicles derived from osteoclasts (IC50=466 nM).{{Prednisolone disodium} web|{Prednisolone disodium} Glucocorticoid Receptor|{Prednisolone disodium} Purity & Documentation|{Prednisolone disodium} Purity|{Prednisolone disodium} custom synthesis|{Prednisolone disodium} Autophagy} Tiludronate also potently inhibits proton transport in yeast microsomal preparations (IC50=3.{{Briquilimab} medchemexpress|{Briquilimab} Protocol|{Briquilimab} Description|{Briquilimab} custom synthesis|{Briquilimab} Epigenetics} 5 microM) and inhibits the activity of purified yeast V-ATPase.PMID:23443926 The inhibition of the osteoclast V-ATPase-mediated proton transport by Tiludronate is rapid, pH-dependent, and reversible.|In Vivo:|Tiludronate exerts a dose-dependent inhibitory activity on bone resorption. Tiludronate could act on mature osteoclasts by reducing their capacity to secrete proton into the resorption space and also by favoring their detachment from the bone matrix. Tiludronate is also tested in other models of osteoporosis. In the castrated male rat model, Tiludronate (5-200 mg/kg; p.o.) prevents the decrease in the skeletal mass, assessed physically by measuring the bone weight and density or chemically by determining the calcium and phosphate content.|Products are for research use only. Not for human use.|